In pancreatic ß-cells the syntaxin 6 (Syn6) SNARE is distributed in the TGN (with spillover into immature secretory granules) and endosomes. A possible Syn6 requirement has been suggested in secretory granule biogenesis, but the role of Syn6 in live regulated secretory cells remains unexplored. We have created an ecdysone-inducible gene expression system in the INS-1 ß-cell line and find that induced expression of a membrane-anchorless, cytosolic Syn6 (called Syn6t), but not full-length Syn6, causes a prominent defect in endosomal delivery to lysosomes, and the TGN, in these cells. The defect appears downstream of the endosomal branchpoint involved in transferrin recycling, and upstream of the steady-state distribution of mannose 6-phosphate receptors. By contrast, neither acquisition of stimulus-competence nor the ultimate size of ß-granules are affected.
Introduction
The final membrane re-modeling required for biogenesis of mature endocrine secretory granules occurs at the stage of clathrin-decorated, immature secretory granules (ISGs), in which a subset of lumenal proteins (Kuliawat et al., 1997) and a subset of membrane proteins (Dittié et al., 1997) are removed and delivered to the endosomal system (Feng and Arvan, 2003) . Of the membrane proteins that are removed from ISGs, some play clear physiological roles in secretory granule biology (Milgram et al., 1994) ; others may be involved in completion of TGN-based re-modeling tasks (Klumperman et al., 1998) ; while still others may have important or even primary functions in the endosomal system (Molloy et al., 1999) . In this report we consider syntaxin 6 (Syn6), a SNARE protein found in ISG membranes (Klumperman et al., 1998) as well as TGN and endosome compartments (Bock et al., 1997; Mallard et al., 2002) . Despite a common assembly scheme, SNARE protein interactions are now generally recognized to provide an important part of the specificity of intracellular membrane fusion events (Parlati et al., 2000; Scales et al., 2000; Bock et al., 2001; Parlati et al., 2002) as well as part of the driving force for membrane fusion (Hu et al., 2003) . In the four-helix bundle contributing to a functional SNARE complex, Syn6 acts as a "light chain" (Fukuda et al., 2000) homologous to the C-terminal helix of SNAP-25 (Bock et al., 2001; Misura et al., 2002) . Syn6 has been found by co-immunoprecipitation to be present in SNARE complexes that include Syn7, Vti1b, and VAMP7 or VAMP8, as part of fusion events within endosomal system (Wade et al., 2001 ).
Some SNARE proteins may be present in ISGs as a prelude to their role in stimulus-dependent granule exocytosis (Regazzi et al., 1996; Wheeler et al., 1996) . However at steady state, molecules such as VAMP4 and Syn6 are distributed in the TGN and ISGs but not mature secretory granules (Bock et al., 1997; Klumperman et al., 1998; Steegmaier et al., 1999; Eaton et al., 2000; Hinners et al., 2003) . Furthermore, VAMP4 and Syn6 are also found abundantly in the endosomes, suggesting recycling of these SNARE proteins between biosynthetic and endocytic pathways . It is unclear if these proteins play roles in membrane fusion events at all stages of their intracellular transport itinerary (Watson and Pessin, 2000) . Clearly, steady state localization does not necessarily establish where the primary intracellular activity of that protein occurs. A case in point is the cation-independent mannose 6-phosphate receptor: there is a major steady state distribution of the receptor in endosomes (Griffiths et al., 1988) even though initial capture of newly-synthesized lysosomal enzymes by the receptor occurs in the TGN.
To date, ISGs have been reported to be associated with three different kinds of membrane fission/fusion events that may involve SNAREs --direct exocytosis of clathrin-decorated ISGs at the cell surface (Orci et al., 1984; Molinete et al., 2001) ; clathrin-coated vesicle budding that initiates the constitutive-like secretory pathway and facilitates delivery of lysosomal proenzymes to the endosomal system (Kuliawat and Arvan, 1992; Kuliawat and Arvan, 1994) ; and homotypic ISG-ISG fusion which might be an obligatory step in mature secretory granule biogenesis (Tooze et al., 1991; Urbe et al., 1998) . It is not clear which, if any, of these fission/fusion events in living cells employ Syn6 in a rate-limiting step. To explore such rate-limiting steps, we have been interested to perturb intracellular Syn6 function in the pancreatic beta cell line, INS-1. We have not pursued microinjection of blocking antibodies because of an interest to generate biochemical as well as morphological phenotypes, and because preliminary investigations have indicated that INS-1 cells are more difficult to microinject than non-beta cell lines. Alternatively, soluble SNARE protein mutants lacking integral membrane anchors are competent to form complexes with endogenous SNAREs and ancillary proteins, and have been repeatedly found to cause specific dominantinterference of membrane fusion events facilitated by their endogenous counterparts (Dascher and Balch, 1996; Olson et al., 1997; Scales et al., 2000; Hua and Scheller, 2001; Geelen et al., 2002; Xu et al., 2002; Collins et al., 2002; Low et al., 2003; Li et al., 2003) . Therefore, with this strategy in mind, we have developed an inducible gene expression system in the INS-1 pancreatic ß-cell line, and used this system to carefully analyze a series of phenotypes associated with induced expression of full-length Syn6 or a truncated, membrane-anchorless form, Syn6t. Our results suggest specific Syn6 involvement in endosomal function in pancreatic ß-cells.
Materials and Methods

Antibodies and other Materials
A rabbit polyclonal Ab against retinoid X receptor α was from Santa Cruz Biotechnology (sc553).
The mAb 3D10 against the N-terminal 26 residues of the Syn6 cytosolic domain has been previously described (Bock et al., 1997) , and was used for Western blotting and immunoprecipitation. A mAb against Syn6 used for immunofluorescence was from Stressgen.
Both polyclonal and monoclonal antibodies against the c-myc epitope were from Santa Cruz Biotechnology. Guinea pig anti-insulin was from Linco Research (St. Charles, MO). Rabbit polyclonal anti-procathepsin B was from Upstate Biotechnologies (Lake Placid, NY). Rabbit polyclonal anti-TGN38 was the kind gift of Dr. S. Milgram (U. North Carolina, Chapel Hill) . A mouse ascites containing mAb clone 2F7.1 against rat TGN38 (Luzio et al., 1990) was from Affinity BioReagents. Two mAbs against Tac were from ATCC (clones 2A3A1H and 7G7B6), with similar results. Rabbit polyclonal antiserum specific for Vti1b was generously provided by the lab of Dr. J. E. Rothman (Memorial Sloan-Kettering Cancer Center, New York). Rabbit polyclonal anti-Vti1a and mouse monoclonal anti-EEA1 were from BD Transduction Labs. Rabbit polyclonal anti-Ykt6 was from Dr. J. Hay (U. Michigan, Ann Arbor MI). A mouse mAb (E2-1) directed against SFV-E2 ( Kielian et al., 1990) was the kind gift of Dr. M. Kielian (Albert Einstein College of Medicine, NY). A rabbit polyclonal antiserum against rat brain CPD was described previously (Varlamov and Fricker, 1998) . All antibodies used in live cell uptake experiments were azide-free.
Anti-calnexin was from Dr. P. Kim (U. Cincinnati College of Med.); anti-synaptophysin/p38 was obtained from the lab of Dr. D. Shields (Albert Einstein College of Medicine, NY); anti-GDI was from Zymed Laboratories. HRP-, FITC-, cy3-and cy2-conjugated secondary antibodies were from Jackson ImmunoLaboratories (West Grove PA). [ 35 S]Methionine/Cysteine (Expre 35 S 35 S) was from New England Nuclear (New Bedford, MA). Methionine/Cysteine-deficient and complete DME, RPMI, leupeptin, pepstatin, and stock chemicals were from Sigma (St. Louis, MO).
Cell Culture
INS-1 cells were cultured in RPMI-1640 medium supplemented with 30 mM sodium bicarbonate, 1 mM sodium pyruvate, 10 mM HEPES pH 7.35, 50 µM beta-mercaptoethanol, 10% fetal bovine serum and 0.1% Penicillin-streptomycin (Gibco/BRL) at 37°C with 5% CO 2 as described (Neerman-Arbez and Halban, 1993) .
DNA Constructs
An N-terminally myc-tagged full-length Syn6 was prepared by PCR mutagenesis with flanking 5' Cla I and 3' Hind III sites; this was subcloned into these sites in pCMV4. In addition, Syn6t was prepared by PCR mutagenesis with flanking 5' Bgl II and a 3' sequence encoding a myc tag and a Hind III site, and this was also subcloned into pCMV4. [Recent studies indicate that both Nterminally tagged an C-terminally tagged syntaxins exhibit normal intracellular trafficking and distribution (Kasai and Akagawa, 2001) ]. Both full-length and Syn6t inserts were excised from pCMV4 with Bgl II/Xba I and subcloned into pIND (InVitrogen). The plasmids encoding Tac-TGN38 (Humphrey et al., 1993; Ghosh et al., 1998) and Tac-Lamp1 (Marks et al., 1996) chimeras were kindly provided by Dr. M.S. Marks (U. Pennsylvania School of Med). The albumin-CPD chimera has been described previously (Kalinina and Fricker, 2003) .
Transfection
Transfection of plasmid DNA was with Effectine (Qiagen) following the manufacturer's protocol.
Stable INS-1 clones transfected with pVgRXR (InVitrogen) were selected with 40 µg/ml zeocin; INS cells positively expressing both ecdysone receptor and retinoid X receptor α by Western blot were termed INS39 cells. INS39 cells were then transfected with the pIND vector to achieve inducible expression of full-length or truncated forms of myc-tagged Syn6, and clones were selected in 20 µg/ml zeocin plus 100 µg/ml G418 (Gibco/BRL) and maintained in the presence of 20 µg/ml zeocin, 50 µg/ml G418. All antibiotics were removed at least 2 days prior to the beginning of experiments. For transient expression experiments, cells were used 2 days after transfection. surface-bound SFV were determined as described (Kielian et al., 1990) .
Uptake and Degradation of 35 S-Semliki Forest Virus
Transferrin Recycling Assay
Cells were grown on 24-well plates; all experimental observations were made in triplicate. To achieve steady-state, cells were incubated with 3 µg/ml 125 I-transferrin in McCoy's binding buffer for 90 minutes at 37°C (a 200-fold excess of unlabeled transferrin was added to some wells to determine nonspecific binding). Before starting the assay, cells were acid washed for 2 min in 0.15 M NaCl, 20 mM citrate, pH 5.0 to remove surface-bound 125 I-transferrin, followed by washing in 150 mM NaCl, 1 mM CaCl 2 , 5 mM KCl, 1 mM MgCl 2 , and 20 mM HEPES pH 7.4. The cells were then incubated in the presence of 3 µg/ml unlabeled transferrin and 10 mM desferroxamine at 37°C. At 2.5, 5, 10, 15 and 20 min, the medium was collected to measure 125 I-transferrin efflux, the cells were solubilized, and radioactivity in both was measured by scintillation counting.
Metabolic Labeling and Stimulation of Secretory Granule Exocytosis
Stably transfected INS-1 clones were seeded two days before experiments in the absence of selectable antibiotics. Cells were induced by the addition of 20 µM ponasterone for 24 h prior to experiments. Cells were pre-incubated for 30 min in methionine and cysteine-free DME, and then pulse labeled with 130 µCi [ 35 S]met/cys for 30 min in the same medium. After labeling, cells were washed three times with ice-cold DME before chase for various times at 37°C in DME containing 5.5 mM glucose and 1% fetal bovine serum. Exocytosis was stimulated in DME containing a combination secretagogue including 10 mM glucose, 1 µM phorbol 12-myristate 13-acetate, 1 mM isobutylmethylxanthine, 1 mM tolbutamide, 10 mM leucine and 10 mM glutamine (Neerman-Arbez and Halban, 1993) . At the end of selected chase periods, media were collected and cells lysed in 1% Triton X-100, 0.1% SDS, 100 mM NaCl, 10 mM EDTA, 25 mM Tris, pH 7.4, plus 1 mU/ml aprotinin, 1 µM leupeptin, 10 µM pepstatin, 5 mM EDTA, 1 µM E64, and 1 mM iodoacetamide.
Cell lysates and chase media were pre-cleared with zysorbin (Zymed Laboratories, South San Francisco CA), normalized to 200,000 trichloroacetic acid precipitable cpm, and then subjected to immunoprecipitation.
Western Blotting of Syn6
This was performed on samples subjected to 10% SDS-PAGE, electrotransferred to nitrocellulose, and blotted with primary antibody against c-myc or syntaxin 6 at 1:1000 dilution and the appropriate secondary IgG-peroxidase conjugate at 1:2000 dilution, followed by enhanced chemiluminescence detection.
Cell Surface Tagging and Recycling of CPD, Albumin-CPD, and Tac-TGN38 to the TGN Cells grown on poly L-lysine-coated coverslips were treated plus or minus 20 µM ponasterone for 24 h. For antibody uptake, cells were incubated either with rabbit anti-albumin (1:150 dilution) or mouse mAb anti-Tac. At the conclusion of the uptake period, the cells were washed twice in ice cold PBS and fixed with 4% formaldehyde for 15 min, washed, permeabilized with 0.1% Triton X-100 in PBS for 15 min, and stained with cy3-conjugated IgG secondary antibody at 1:500 dilution.
In addition, these fixed permeabilized cells were incubated with anti-TGN38 (either rabbit polyclonal or mouse mAb, depending upon which antibody was used for uptake) and a cy2-conjugated anti-mouse IgG secondary antibody at 1:100 dilution.
Electron Microscopy
Syn6-21 cells and Syn6t-10 cells plus and minus one day of ponasterone treatment, grown on tissue culture plastic, were fixed with 2.5% glutaraldehyde and 2% formaldehyde in 0.1 M Na cacodylate, pH 7.0 for 2 h at room temperature and postfixed with 1% osmium tetroxide. The cells were dehydrated in ethanol and propylene oxide, infiltrated and embedded in LX112 resin (LADD Research Industries, Burlington VT), thin sectioned, stained with lead citrate and 1% uranyl acetate, and then examined at a fixed magnification in a JEOL 1200EX transmission electron microscope at 80kv. Captured images were then projected and each individual secretory granule profile outlined and analyzed for precise granule cross-sectional area by the Investigator HT Analyzer program (version 2.1, Genomic Solutions). Finally, mean granule diameters were calculated from the crosssectional areas, based on a spherical geometry.
Membrane Sedimentation and Sucrose-Velocity Gradient Centrifugation Assays
Cells grown on 15 cm dishes were either uninduced or induced for 24 h with 20 µM ponasterone.
The cells were washed twice with ice cold PBS plus 0.2 mM MgCl 2 , plus 1 mU/ml aprotinin, 1 µM leupeptin, 10 µM pepstatin, 5 mM EDTA, 1 µM E64, and 1 mM iodoacetamide. For membrane sedimentation, the cells were scraped and lysed in buffered 0.3 M sucrose plus protease inhibitors by 8 passages through 21 g needle followed by eight passages through a ball-bearing cell cracker with 0.002 inch clearance. 0.5 ml of cell homogenate was then spun at 67,500 g h. Pellets were resuspended in an equal volume of the same buffer, and equal aliquots of pellet and supernatant fractions were taken for SDS-PAGE and immunoblotting. In preparation for sucrose-velocity gradient centrifugation, cells were lysed the same way but in in 0.1 M KCl, 1mM EDTA, 1% glycerol, and 10 mM Hepes pH 7.35 plus protease inhibitors. Post-nuclear supernates were loaded onto 5%-20% Hepes-buffered sucrose gradients, spun in swinging buckets for 1 h at 100 000 g, and collected in 12 fractions, with fraction 12 including the resuspended pellet. The fractions were analyzed by SDS-PAGE and immunoblotting.
Results
Inducible expression of Syn6 and Syn6t in INS cells
As soluble cytosolic domains of a wide variety of syntaxins have been found to confer dominant interfering phenotypes (Dascher and Balch, 1996; Olson et al., 1997; Scales et al., 2000; Hua and Scheller, 2001; Geelen et al., 2002; Xu et al., 2002; Collins et al., 2002; Low et al., 2003; Li et al., After overnight induction of gene expression in the presence of ponasterone, immunoblotting with a monoclonal anti-Syn6 revealed inducible expression of Syn6t (~29kDa) in the Syn6t-10 clone or full-length Syn6 (~30kDa) in Syn6-2 and Syn6-21 clones, respectively (Fig. 1A) . In addition, all INS cells express the ~26kDa endogenous Syn6 (Fig. 1A) . After 24 h of ponasterone treatment, the 6t-10 clone showed levels of Syn6t ~5.5-fold (n=6) greater than endogenous Syn6 and Syn6-21
showed levels of full-length Syn6 ~4.4-fold greater (n=8) than endogenous Syn6. Not surprisingly, Syn6t had a shorter half-life than endogenous Syn6, which showed no decrease in levels of immunoreactive protein in cells 4 h after cycloheximide treatment ( 
Dominant negative Syn6t causes specific defects in the endosomal system of INS cells
To evaluate endosomal function, we first examined whether Syn6t affected the lysosomal delivery/degradation of ligands endocytosed via the well-established clathrin-coated vesicle pathway. For this, we employed a standard assay measuring lysosomal degradation of endocytosed 35 S-labeled Semliki Forest Virus (SFV, Martys et al., 1996) that has been previously examined in pancreatic ß-cells (Turner and Arvan, 2000) . Lysosomal delivery/degradation of 35 S-labeled SFV was statistically indistinguishable between INS cells, INS39 cells, INS39 cells transfected with fulllength Syn6 in the absence or presence of inducer, or Syn6t-10 cells in which Syn6t was not expressed. However, after induction of Syn6t expression, there was dramatic inhibition of the rate of SFV degradation (Fig. 3A) . The magnitude of this effect is large; greater than or equal to the inhibition obtained upon 100 nM wortmannin addition to CHO cells (Martys et al., 1996) or 10 µg/ml brefeldin A added to INS-1 pancreatic ß-cells (Turner and Arvan, 2000) . As no significant differences in surface binding or initial internalization of surface-bound SFV were observed (SFV uptake at 5 min is shown visually in Fig. 5, below) , the data suggest that Syn6t induces a dominant interfering phenotype during endosome→lysosome maturation in INS cells.
To test whether the endosomal defect induced by Syn6t was in the most proximal portion of the endocytic pathway, we examined transferrin uptake and recycling from these cells. Not only was Syn6t expression without effect on transferrin uptake (not shown), it also had no effect on transferrin return from the endocytic pathway, via recycling endosomes, back to the medium (Fig.   3B ). This suggests that the endosomal defect induced by Syn6t is located downstream of the transferrin recycling branchpoint.
To determine whether a similar endocytic pathway defect could be identified for another marker that defines the endosome→lysosome trafficking route, we transiently transfected INS cells to express a Tac-Lamp1 chimeric protein (Marks et al., 1996) in which the cytoplasmic tail of Lamp1 was appended to the lumenal and transmembrane domains of a monomeric integral membrane reporter protein, the interleukin-2 receptor alpha-chain (Tac). In either INS39 cells or Syn6-21 cells It is easier to perform morphological studies of the endocytic pathway using SFV rather than the Tac-Lamp1 chimera as the former method does not require transfection, and endocytosis of the antigenic marker occurs in >95% of cells. A mAb against the E2 epitope was used to track SFV after it had been pre-bound to the cell surface at 4°C (Fig. 5A) . 5 minutes after warm-up of cells to 37°C, virus was detected at the cell perimeter (upper panels, Fig. 5A ). In whole cell immunofluorescence using cells with induced expression of full-length Syn6, by 20 min after warm-up, virions could clearly be chased into the cell interior, but beginning after 35 min, the epitope to which the anti-E2 mAb was directed became substantially less immunoreactive (Fig. 5A, botton left panel), suggesting epitope masking, a conformational change, or degradation. By contrast, in cells with induced Syn6t expression, the intracellular staining intensity of the SFV E2 epitope largely persisted (Fig. 5A, bottom right panel) . To determine whether, at this time, virions had advanced as far as mannose-phosphate receptor-positive late endosomes, the experiment was repeated but this time using confocal immunofluorescence microscopy and double labeling with anti-E2 and anti-mannose-phosphate receptor antibodies (Fig. 5B) . Once again in both types of INS cells the SFV particles initially decorated the cell perimeter and by 35 min after warm-up, cells with induced expression of the full-length protein exhibited a significant decrease in detection of the E2 epitope ( Fig. 5B lower left panel) . At this time in cells with induced expression of Syn6t (Fig. 5B lower right panel), SFV immunofluorescence persisted (red), but the staining did not significantly co-localize with mannose-phosphate receptors (green).
Eventually at later times SFV immunofluorescence also disappeared in Syn6t-expressing cells (not shown). These data strongly suggest that Syn6t induces a defect in delivery of SFV to later endosomal compartments where loss of immunofluorescence is likely to occur, although this is a kinetic block rather than a permanent one.
Effects of dominant-interfering Syn6t on secretory granule biogenesis
Syn6t-10 cells that had been untreated or treated with inducer were pulse labeled with 35 S-amino acids for 30 min and then chased in the absence of added secretagogues for up to 4 h; under these conditions, a modest fraction of proinsulin was secreted especially during the first 2 h of chase, and this was independent of Syn6t expression (Fig. 6A) . In a fifth and final hour, duplicate wells were chased further in the absence or presence of secretagogue; regardless of Syn6t expression, the stimulus elicited release of comparable fractions of mature insulin from the regulated secretory pathway (Fig. 6A ). Since Syn6 has been reported to be required for homotypic fusion of small ISGs , it seemed possible that Syn6t might allow for the production of small ISGs that can undergo exocytosis but not fuse with each other, resulting in a smaller-than-normal granule population. We therefore performed electron microscopy at fixed magnification of INS cells not expressing or expressing the dominant-interfering Syn6t mutant for 1 day, and measured the profile areas and diameters of granules under each condition. Secretory granules in ponasterone-treated INS cells have a half-life of ~17h; therefore the majority (65%) of granules in the 6t-10 cells were made de novo during a day of continuous Syn6t expression (Fig. 6B ). In the absence of Syn6t, insulin secretory granule diameters averaged 209 ± 121 nm (n = 337 granules) and in the presence of induced Syn6t expression for a full day the uncorrected diameters still averaged 209 nm ± 177 nm (n=345 granules; the measurements were uncorrected for the variation obtained when planar sections are cut at random depths through spherical granules, which raises the standard deviations).
Thus, Syn6t expression does not obviously impair the ability of insulin secretory granules to undergo regulated release or to achieve their normal final size. To look for more subtle phenotypes in initial acquisition of stimulus-competence, we used a pulse-chase format to more closely examine discrete 30-min intervals during the first 2 h after proinsulin biosynthesis. Stimulus-dependent secretion of insulin-containing peptides was not less in Syn6t-expresssing cells (filled symbols, Fig. 7A ) compared to that in cells induced to express full-length Syn6 (open symbols). There was a delay in the endoproteolytic processing from proinsulin to insulin in Syn6t-expresing cells (Fig.   7B ); nevertheless, quite unlike the major delay in the lysosomal arrival of endocytic pathway markers (that dramatically persists after 120 min, see Figs. 3-5), there was no difference in the insulin content of ISGs after 120 min of chase (Fig. 7B) . Together, the data indicate that Syn6t expression does not cause any detectable defect in biogenesis of mature insulin secretory granules, although there is a modest lag in intragranular conversion to insulin.
Syn6t expression results in minor mis-sorting of newly-synthesized lysosomal cathepsin B
Since Syn6t expression has obvious effects on the endocytic pathway (Figs. 3-5) , we proceeded to study indirectly the effect of Syn6t expression on the recycling/availability of mannose phosphate receptors by examining newly-synthesized lysosomal enzyme delivery to lysosomes in these cells (as measured by intracellular conversion of procathepsin B -ProB -to the mature lysosomal form). In the absence or presence of expression of the full-length Syn6 (Fig. 8A , upper left panel), the ProB precursor is initially present at the end of the pulse labeling but is largely converted to mature B after a 4 h chase (Fig 8A, upper right Previously published studies of INS cells have indicated that most newly-synthesized ProB sorting has occurred within 1.75 h of chase during which there is modest constitutive and constitutive-like secretion; thereafter, there is little or no unstimulated or stimulated release of ProB (Kuliawat et al., 1997; Turner and Arvan, 2000) . To determine the extent of spillover of ProB from the TGN into ISGs of Syn6t-expressing cells, we examined unstimulated and stimulated secretion for one hour beginning after the first 1.75 h had elapsed. During the first 1.75 h in either the absence or presence of inducer, there was very little newly-synthesized proinsulin released (Fig. 8B, bottom) . Further, in agreement with earlier results (Fig. 6A) , there was clear stimulus-dependent release of processed insulin recovered during the ensuing hour (Fig. 8B, bottom) . From the identical samples, cells with Syn6t expression exhibited an increase in the unstimulated release of ProB during the first 1.75 h, consistent with modest mis-sorting into constitutive and constitutive-like secretory pathways ( Fig.   8B top, lane 2). Moreover, during the ensuing hour in cells treated with inducer, the stimulus-dependent release of ProB (Fig. 8B top, compare lanes 5 and 6) was of a small magnitude such that it resulted in little depletion of the labeled cathepsin B remaining in the cell lysate (lanes 9 and 10), despite stimulus-dependent insulin release from the same samples sufficient to cause marked insulin depletion from the cells (lower panel lanes 9 and 10). These data confirm that the overall extent of ProB mis-sorting into constitutive and constitutive-like pathways (as well as ProB persistence in secretory granules) was relatively minor, and most intracellular ProB that did persist at 165 min of chase was not depleted by secretagogue and was therefore likely to already be in transit beyond the secretory pathway, ie, delayed while en route through the endosomal system.
Recycling to the TGN in Syn6t-expressing INS cells
Recycling of TGN resident proteins can be followed by antibody-or other-tagging of the subpopulation of molecules that are cycling via the plasmalemma, and then following the surfacetagged molecules as they return to the TGN via the endosomal system (Gartung et al., 1985; Molloy et al., 1994; Banting and Ponnambalam, 1997; Varlamov and Fricker, 1998) . In numerous preliminary experiments we examined endocytic return of surface-tagged endogenous carboxypeptidase D and found that, slower than previously reported for recycling of this antigen in
AtT-20 cells (Varlamov and Fricker, 1998) , a 2 h period of continuous antibody uptake was optimal to achieve a concentrated TGN-based signal of surface-tagged molecules in the entire population of These experiments were extended to employ transiently expressed Tac-TGN38 (Mallard et al., 2002) . In Fig. 9 experiment Â, cells not expressing Syn6t delivered the expressed Tac-TGN38 (red, cells marked with arrows) to the TGN38-positive compartment (green) and cells expressing Syn6t
showed delayed delivery of Tac-TGN38 (right panel). Finally, using confocal immunofluorescent microscopy in experiment ¯, it was apparent that whereas INS cells not expressing Syn6t showed excellent Tac-TGN38 delivery to the TGN38-positive compartment, even in Syn6t-expressing cells where Tac-TGN38 reached a predominant juxtanuclear location (nuclear position denoted with "N"), the chimera still did not co-localize with the TGN marker in these cells. Quantitatively, when combining all experiments expressing either Alb-CPD or Tac-TGN38, of INS cells not expressing Syn6t, 100% achieved co-localization of these markers with endogenous TGN38; whereas for cells that do express Syn6t, 5.6% of cells achieved co-localization with TGN38, 13.9% achieved partial co-localization, and 80.5% of cells achieved no co-localization whatsoever. These data are consistent with results in CHO cells in which efficient endosomal Tac-TGN38 return to the TGN is kinetically impaired by overexpressing a construct quite similar to Syn6t (Mallard et al., 2002) .
Syn6t-expression alters Vti1b distribution in pancreatic ß-cells
At the molecular level, the role of Syn6 in efficient endosomal delivery of proteins might be explained by associations with a number of potential Syn6-interacting proteins (Simonsen et al., 1999; Nagamatsu et al., 2001) . Using available antibodies, we could not convincingly demonstrate co-immunoprecipition of Syn7, Vti1a, Ykt6, mVps45 or EEA1 with Syn6t in INS cells. We therefore tried another approach: as Syn6t has different sedimentation properties to that of full-length Syn6 (Fig. 2) , INS cells expressing or not expressing Syn6t were lysed in the complete absence of detergents and post-nuclear supernates were analyzed by 5-20%
sucrose-velocity gradient centrifugation to examine the relative distribution of potential interactors.
As shown in Fig. 10 , Western blotting for Syn6 in INS-1 cells (left set of panels) showed the endogenous protein recovered exclusively at the bottom of the gradient (fraction 12). This also matched the distribution of endogenous Vti1b (Fig. 10) , and the integral membrane protein marker, calnexin ("Clnx", Fig. 10 ) was similarly distributed. In 6t-10 cells (right set of panels), endogenous Syn6 showed the same distribution while induced expression of Syn6t was recovered in the upper four fractions (top gradient -upon overexposure, a very small fraction of Syn6t was also recovered in fraction 12), and this distribution of soluble Syn6t is similar to that observed for the soluble GDI marker protein in control cells. Two SNARE proteins were recovered both in apparently soluble forms as well as at the bottom of the gradient (in markedly different proportions), namely, Vti1a and Ykt6; the latter distribution has also been reported by others (Hasegawa et al., 2003) . However, neither of these two proteins, nor the early endosomal antigen EEA1, was unequivocally altered by Syn6t expression. By contrast, upon expression of Syn6t, the distribution of Vti1b was distinctly shifted in part to the uppermost 4 fractions of the sucrose-velocity gradient (right set of panels). We do not know if the redistribution of a subset of Vti1b molecules reflects their extraction from membranes because the membrane anchor of Vti1b contains the highly unusual negatively charged (Glu) residue midway along its transmembrane domain (Advani et al., 1998) . We also entertained the possibility that this shift could reflect Vti1b relocation into a population of microvesicles (Antonin et al., 2000) rather than to a soluble cytosolic population, but this seemed unlikely because synaptic-like microvesicles are still recovered at the bottom of the detergent-free gradient, as judged by the distribution of the marker synaptophysin/p38 (bottom panel).
Vti1 in yeast is required for all traffic to the yeast lysosome (von Mollard et al., 1997) and human
Vti1 can functionally substitute for yeast Vti1 in vti1 mutant yeast (von Mollard and Stevens, 1998).
The mammalian Vti1b in particular is localized to endosomes (Kreykenbohm et al., 2002) ; and Syn6 is known to form a complex with Vti1b in other cell types (Xu et al., 1998; Wade et al., 2001) . We therefore used an IP-Western co-precipitation assay to determine if Vti1b could associate with Syn6 and Syn6t in INS cells. Syn6-21, 6t-10, or control INS39 cells were immunoprecipitated with anti-myc mAb or anti-myc polyclonal Ab. These immunoprecipitates were immunoblotted with polyclonal anti-myc in order to confirm immunoprecipitation (Fig. 11, upper left and upper middle panels). As expected, no blottable myc band could be recovered from control INS39 cells. Myc-tagged protein expression was also confirmed by direct immunoblotting of lysates of cells that had not been previously immunoprecipitated (Fig. 11, upper right panel) .
Anti-myc immunoprecipitates subjected to SDS-PAGE nd electrotransfer were immunoblotted with anti-Vti1b antibody (lower left and lower middle panels). No Vti1b could be immunoblotted from immunoprecipitates of cells not expressing a myc-tagged Syn6 protein. However, Vti1b was coprecipitated using anti-myc in lysates of cells with induced expression of either full-length Syn6 or Syn6t. Finally, all three of the cell lines could generate co-precipitation of Vti1b when the initial immunoprecipitation was performed with anti-Syn6 mAb (Fig. 11, lower right panel) . Together, the data in Figs 10 and 11 are consistent with Syn6t competing for a subset of potential Syn6 SNARE interactions including Vti1b within the endosomal system.
Discussion
Dominant negative effects of Syn6t on the endocytic pathway
Syn6 is a long-lived protein (Fig. 1B) that is localized to endosomes and the TGN/ISGs (Bock et al., 1996; Bock et al., 1997; Klumperman et al., 1998; Steegmaier et al., 1999; Simonsen et al., 1999; Watson and Pessin, 2000; Wade et al., 2001) . Thus, it is widely believed that Syn6 regularly recycles and, kinetically speaking, exit from endosomal intermediates and the biosynthetic pathway represent the slowest steps in the Syn6 cycling itinerary. The issue addressed in the present study is where does the Syn6 SNARE potentially participate in a ratelimiting step in protein trafficking, rather than functioning primarily as a cargo protein. Based on actions of the dominant-negative Syn6t in INS cells, the evidence presented implicates a primary activity of Syn6 in the endosomal system of pancreatic ß-cells.
The predominant distribution of Syn6 in endosomes and the TGN in itself might suggest that Syn6
participates directly in endosome→TGN return; indeed, a construct called Syn6 cyto (which is nearly identical to our Syn6t) has been reported to inhibit TGN return of a Tac-TGN38 chimera (Mallard et al., 2002) , and we have confirmed these findings upon Syn6t expression in INS cells both for Tac-TGN38 and for Alb-CPD (Fig. 9 ). This inhibition represents primarily a kinetic slowing of the return route while the TGN exit step remains slow or slower, as the steady state distributions of TGN markers (CPD, TGN38) do not appear altered ( Fig. 1C and Fig. 8) . Similarly, upon Syn6t expression in INS cells, there is a significant kinetic defect in endocytic cargo delivery from the cell surface to lysosomes as measured biochemically (Fig. 3A) or morphologically (Fig. 4, Fig. 5A ).
This defect appears to occur downstream of the branchpoint for transferrin recycling (Fig. 3B ) yet upstream of mannose-phosphate receptor-enriched late endosomes (Fig. 5B ). Upon expression in INS cells (Fig. 1, 2) , we observe co-immunoprecipitation of Syn6t with Vti1b (Fig. 11) [an endosomal SNARE (Kreykenbohm et al., 2002) ] and a change in the intracellular distribution of Vti1b (Fig. 10) , consistent with the idea that Syn6t works by competing for endosomal Syn6 SNARE partners (Simonsen et al., 1999; Mills et al., 2001; Wade et al., 2001; Kreykenbohm et al., 2002; Mallard et al., 2002) , altering the intracellular distribution of at least one, to influence cargo progression from early endosomes to lysosomes or the TGN.
Effects of Syn6t expression on the biosynthetic pathway
In the literature, one potential Syn6-interactor (endobrevin/VAMP8) has been implicated in playing a physiological role in the exo-endocytosis cycle of insulin secretory granule (Nagamatsu et al., 2001) . Even more important to the current considerations is the longstanding view that new secretory granule biogenesis involves re-utilizing many secretory granule membrane constituents that have recycled via the endocytic pathway (Farquhar, 1983) . Given the clear positive findings of the current study implicating Syn6 function within the endosomal system, one of our central goals was then to test whether Syn6t could interfere significantly with secretory granule formation.
Indeed, a recent report has suggested that Syn6 is involved in secretory granule biogenesis by facilitating homotypic fusion of ISGs, this based on an in vitro fusion assay using ISGs from PC12 cells . However, positive evidence indicating homotypic fusion of ISGs in live regulated secretory cells -even PC12 cells -has not yet been obtained (Rudolf et al., 2001) ; nor has this step yet been shown to be essential for granule biogenesis in endocrine, exocrine, or neural cells. Moreover, a purified recombinant soluble Syn6 construct containing Syn6 2→231 (only slightly smaller than our Syn6t 1→236 ) does not inhibit readout in the in vitro assay . In agreement, the present data indicate that Syn6t does not obviously impair the crosssectional area of the mature insulin granule population (Fig. 6 ), or the formation of new secretory granules as judged by acquisition of secretagogue-stimulated exocytosis (Fig. 7A ), even as it does produce overt effects on the endosomal system.
What is observed in the biosynthetic pathway upon Syn6t expression is a modest lag in intragranular conversion to insulin (Fig. 7B ) and a small lysosomal enzyme mis-sorting phenotype (Fig. 8) , including increases in the amount of ProB spilling into constitutive and constitutive-like secretory pathways and exhibiting abnormally prolonged residence in secretory granules as well as in post-secretory (ie, endosomal) compartments. However, as mannose-phosphate receptordependent trafficking of ProB is only marginally affected, we suggest that the endosomal step(s)
inhibited by Syn6t expression is likely to be largely proximal to the endosomal site of entry of most mannose-phosphate receptors. This is also consistent with kinetic slowing of SFV endocytic transport at a site proximal to the steady state distribution of of mannose-phosphate receptors (Fig.   5B ). Moreover, the fact that the steady state distribution of TGN proteins is not obviously affected upon Syn6t expression provides a further indication that secretory pathway operations are likely to proceed relatively normally in spite of slowed kinetics of protein return from the endosomal system.
Thus we conclude that Syn6t provides only modest and potentially indirect interference with regulated and constitutive secretory pathways, and in TGN sorting of lysosomal enzymes.
In summary, the data obtained in the pancreatic ß-cell line, INS-1, suggest that Syn6 plays a potentially rate-limiting role in endocytic delivery both to lysosomes and the TGN. Given the recent finding that certain insulin secretory granule membrane proteins may be irreversibly cleaved upon stimulated exocytosis at the plasma membrane (Ort et al., 2001) , and thus cannot be reutilized intact, we believe the question of how important endosome-to-TGN return really is for ongoing secretory granule biogenesis remains open, and needs to be re-visited. 
